From study baseline to the end of follow-up, GLP-1RAs treatment resulted in statistically significant decreases in weight (MD = -2.32 kg, 95% CI: -4.21 to -0.43) and BMI (MD = -0.82 kg/m 2 , 95% CI: -1.47 to -0.17)
Jeremy Faust, emergency physician at Brigham and Women's Hospital in Boston, joins CBS News to assess the safety and risks of the practice.
References and Clinical Sources ClinicalTrials.gov
That said, I did not feel that the appetite suppression was as much as I needed
Our goal was to create an accessible, science-backed system that fills essential nutrient gaps while also helping individuals feel their best throughout their weight-loss journey by addressing nutrition-related issues that are associated with GLP-1 drugs, Daley said.
Corn, wheat, soy and sugar